Android app Apple app link

This software stock can gain more than 50% after being held back by macroeconomic concerns, says BTIG

By CNBC   |   2 weeks ago
This software stock can gain more than 50% after being held back by macroeconomic concerns, says BTIG

Despite macroeconomic concerns in the biopharmaceutical sector, investment bank BTIG upgraded Doximity to buy, citing strong software demand from medical professionals. Analysts believe the company is well-positioned to overcome challenges and see a potential 54% upside in the stock.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.